Izana Bioscience Namilumab May Treat COVID-19 Pneumonia
The trial tested namilumab as a potential therapeutic to treat patients who are hospitalized with COVID-19 pneumonia.
The trial tested namilumab as a potential therapeutic to treat patients who are hospitalized with COVID-19 pneumonia.
The trial tested namilumab as a potential therapeutic to treat patients who are hospitalized with COVID-19 pneumonia.
Read More